In this section

Collaborative

Overview

MedTechOne Collaborative is part of MedTechONE, which helps tackle challenges faced by those innovating in the MedTech space and supports MedTech entrepreneurs at Imperial College London.
The collaborative branch of MedTechONE specifically works with local and national networks of different clinical specialties. This includes coordinating national evaluations of our technologies in wider clinical trials, as well as accepting incoming devices into our medical technologies programme for support at all stages of translation, from first-in-human to early adoption.

What we do

Our Distribution

The MedTechONE Collaborative activities will be distributed across Imperial College Healthcare NHS Trust Hospitals:

Charing Cross, Queen Charlottes’
Chelsea Hospital
Hammersmith Hospital
St Mary’s Hospital
Western Eye Hospital
Imperial College London/ ICL NHS Trust Academic Health Science Centre (AHSC), the NIHR Imperial College Biomedical Research Centre (BRC) and the NIHR Clinical Research Network for Northwest London communities
Associated centres such as the Imperial Experimental Cancer Medicine Centre (ECMC), and Imperial College Clinical Trials Unit

Our Impact

Additional clinical translational resources and support to the ecosystem
A dramatic growth in MedTech activity and practical translation
Clear pathways for translational journeys

Our Support

Assistance with trials setup and management  
Coordinating evaluations of technologies in wider clinical trials 
Guidance for proof of concept 
Clinical trials support (REC through to study management/ documentation support) 
Signposting to appropriate funding and calls/ who to talk to about spinouts 
Directing researchers to existing support  
Communication/ dissemination of results 
Adoption of new medical devices within the ICNHS Trust and beyond